MedPath

Effect of esomeprazole on symptom relief in patients with PPI-refractory GERD

Not Applicable
Conditions
PPI-refractory GERD
Registration Number
JPRN-UMIN000007116
Lead Sponsor
Osaka City University, Department of Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1. Esomeprazole allergy 2. Prescribing atazanavir sulfate 3. Esophageal stricture, IBS, IBD, Zollinger-Ellison syndrome, Malabsorption syndrome 4. Active gastric or duodenal ulcer by endoscopy 5. Sever Heart, kideny, liver diseases 6. Upper GI surgery 7. Pregnancy 8. PPI administration 14 days before trial 9. Co-treatment with H2RA, prokinetcis, other PPI etc. 10.Other drugs (diazepam, digoxin, etc.)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath